|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 2018加拿大心境障碍与焦虑障碍治疗协作组/国际双相障碍学会指南:双相障碍的管理显示文摘加拿大心境障碍与焦虑障碍治疗协作组(Canadian Network for Mood and Anxiety Treatments,CANMAT)曾于2005年发布了第1版双相障碍管理指南,并分别于2007、2009和2013年对该指南进行了更新,其中最近的2次更新是与国际双相障碍学会(International Society for Bipolar Disorders,ISBD)合作完成。2018版CANMAT/ISBD双相障碍治疗指南(以下简称指南)反映了自2005年首版指南发表以来本领域取得的重大进展,包括疾病诊断与疾病管理的更新以及药物治疗与心理治疗的近期研究进展。这些前沿进展中综合考虑了循证证据的级别,并基于治疗疗效、临床实践经验、安全性、耐受性和药物导致的转相风险等,对一线、二线及三线治疗方案进行了简明而清晰的推荐。本指南中新增内容涵盖了双相Ⅰ型障碍(BD-Ⅰ)的躁狂发作急性期、抑郁发作急性期和双相障碍维持期的一线及二线治疗推荐等级划分。这种对治疗推荐等级的划分综合考虑了治疗方法对双相障碍不同时相的影响,将进一步帮助临床医生做出基于循证证据的治疗决策。锂盐、喹硫平、双丙戊酸盐、阿塞那平、阿立哌唑、帕利哌酮、利培酮和卡利拉嗪单药或联合使用被推荐为躁狂发作急性期的一线治疗选择。BD-Ⅰ抑郁期的一线治疗选择包括喹硫平、鲁拉西酮、锂盐、拉莫三嗪单药,鲁拉西酮联合锂盐或双丙戊酸盐或拉莫三嗪辅助治疗。尽管急性期治疗有效的药物通常应继续用于BD-Ⅰ的维持期治疗,但也存在一些特殊情况(例如抗抑郁药)。现有数据表明,锂盐、喹硫平、双丙戊酸盐、拉莫三嗪、阿塞那平和阿立哌唑单药或联合治疗应被视为维持治疗的初始或更换治疗方案时的一线选择。除了探讨BD-Ⅰ的相关问题外,本指南中还对双相Ⅱ型障碍(BD-Ⅱ)的临床管理进行了系统回顾并给予治疗推荐,同时针对特殊人群也有相关推荐,如处于各个生殖周期的女性、儿童、青少年和老年人。此外,本指南中还讨论了特定精神疾病及共病(如物质滥用、焦虑障碍和代谢性疾病)的影响。最后,本指南中概述了安全性和药物监测的相关问题。CANMAT/ISBD工作组希望本指南能够成为全球临床医生的实用工具。 | Lakshmi N Yatham Sidney H Kennedy Sagar V Parikh Ayal Sehaffer David J Bond Benicio N Frey Verinder Sharma Benjamin I Goldstein Soham Rej Serge Beaulieu Martin Alda Glenda MaeQueen Roumen V Milev Arun Ravindran Claire O'Donovan Diane Mclntosh Raymond W Lam Gustavo Vazquez Flavio Kapczinski Roger S Melntyre Jan Kozicky Shigenobu Kanba Beny Lafer Trisha Suppes Joseph R Calabrese Eduard Vieta Gin Malhi Robert M Post Michael Berk 胡晨(译) 王刚(译) | 2019 | 中华精神科杂志2019，52，1： | 25 |
| 2 | Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association显示文摘 | Alan S. Go Dariush Mozaffarian Véronique L. Roger Emelia J. Benjamin Jarett D. Berry William B. Borden Dawn M. Bravata Shifan Dai Earl S. Ford Caroline S. Fox Sheila Franco Heather J. Fullerton Cathleen Gillespie Susan M. Hailpern John A. Heit Virginia J. | 2013 | Circulation2013，，1： | 5 |
| 3 | Prenatal diagnosis and assessment of congenital spinal anomalies: Review for prenatal counseling显示文摘The last two decades have seen continuous advances in prenatal ultrasonography and in utero magnetic resonance imaging. These technologies have increasingly enabled the identification of various spinal pathologies during early stages of gestation. The purpose of this paper is to review the range of fetal spine anomalies and their management, with the goal of improving the clinician's ability to counsel expectant parents prenatally. | Vidyadhar V Upasani Pamela Deaver Ketwaroo Judy A Estroff Benjamin C Warf John B Emans Michael P Glotzbecker | 2016 | World Journal of Orthopedics2016，7，7： | 4 |
| 4 | Executive Summary: Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association显示文摘 | Alan S. Go Dariush Mozaffarian Véronique L. Roger Emelia J. Benjamin Jarett D. Berry William B. Borden Dawn M. Bravata Shifan Dai Earl S. Ford Caroline S. Fox Sheila Franco Heather J. Fullerton Cathleen Gillespie Susan M. Hailpern John A. Heit Virginia J. | 2013 | Circulation2013，，1： | 4 |
| 5 | Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial显示文摘 | Ronald P DeMatteo Karla V Ballman Cristina R Antonescu Robert G Maki Peter WT Pisters George D Demetri Martin E Blackstein Charles D Blanke Margaret von Mehren Murray F Brennan Shreyaskumar Patel Martin D McCarter Jonathan A Polikoff Benjamin R Tan Kouros | 2009 | The Lancet2009，，9669： | 2 |
| 6 | Inhibition of Cdk5 increases osteoblast differentiation and bone mass and improves fracture healing显示文摘Identification of regulators of osteoblastogenesis that can be pharmacologically targeted is a major goal in combating osteoporosis,a common disease of the elderly population. Here, unbiased kinome RNAi screening in primary murine osteoblasts identified cyclin-dependent kinase 5(Cdk5) as a suppressor of osteoblast differentiation in both murine and human preosteoblastic cells. Cdk5 knockdown by si RNA, genetic deletion using the Cre-lox P system, or inhibition with the small molecule roscovitine enhanced osteoblastogenesis in vitro. Roscovitine treatment significantly enhanced bone mass by increasing osteoblastogenesis and improved fracture healing in mice. Mechanistically, downregulation of Cdk5 expression increased Erk phosphorylation, resulting in enhanced osteoblast-specific gene expression. Notably, simultaneous Cdk5 and Erk depletion abrogated the osteoblastogenesis conferred by Cdk5 depletion alone, suggesting that Cdk5 regulates osteoblast differentiation through MAPK pathway modulation. We conclude that Cdk5 is a potential therapeutic target to treat osteoporosis and improve fracture healing. | Mubashir Ahmad Benjamin Thilo Krüger Torsten Kroll Sabine Vettorazzi Ann-Kristin Dorn Florian Mengele Sooyeon Lee Sayantan Nandi Dilay Yilmaz Miriam Stolz Naveen Kumar Tangudu David Carro Vázquez Johanna Pachmayr Ion Cristian Cirstea Maja Vujic Spasic Aspasia Ploubidou Anita Ignatius Jan Tuckermann | 2022 | Bone Research2022，10，3： | 2 |
| 7 | Executive Summary: Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association显示文摘 | Véronique L. Roger Alan S. Go Donald M. Lloyd-Jones Emelia J. Benjamin Jarett D. Berry William B. Borden Dawn M. Bravata Shifan Dai Earl S. Ford Caroline S. Fox Heather J. Fullerton Cathleen Gillespie Susan M. Hailpern John A. Heit Virginia J. Howard Bret | 2012 | Circulation2012，，1： | 2 |
| 8 | 遗传性肥胖与心房颤动的关系显示文摘观察性研究已经确定了体质量指数(body mass index,BMI)与心房颤动之间的关联。然而,从观察性研究中推断因果关系会受到混杂因素、逆因果关系和偏倚的影响。该研究的主要目的是应用BMI的遗传学预测因子评估BMI与心房颤动之间的因果关系。方法:纳入1987-2002年期间在美国、冰岛和荷兰实施的7个前瞻性人群队列研究中基线无心房颤动的欧洲血统个体51 646人, | 刘莉 叶鹏 Chatterjee NA Giulianini F Geelhoed B Lunetta KL Misialek JR Niemeijer MN Rienstra M Rose LM Smith AV Arking DE Ellinor PT Heeringa J Lin H Lubitz SA Soliman EZ Verweij N Alonso A Benjamin EJ Gudnason V Stricker BH van der Harst P Chasman DI Albert CM | 2017 | 中华高血压杂志2017，25，2： | 2 |
| 9 | Tuberculum sellae meningiomas:microsurgical anatomy and surgical technique显示文摘 | Benjamin V | 2002 | Neurosurgery2002，51，6： | 1 |
| 10 | What Are Ontologies,and Why Do We Need Them?显示文摘 | Chandrasekaran J Josephson R Benjamins V R | 1999 | IEEE Intelligent Systems1999，1999，： | 1 |
| 11 | Knowledge engineering,principles and methods显示文摘 | STUDER R BENJAMINS V R FENSEL D | 1998 | Data and Knowledge Engineering1998，25，12： | 1 |
| 12 | Knowledge Engineering,Principles and Methods显示文摘 | S TUDER R BENJAMINS V R FENSEL D | 1998 | Data and Knowledge Engineering1998，25，12： | 1 |
| 13 | Knowledge Engineering: Principles and Methods显示文摘 | Studer R BENJAMINS V R FENSEL D | 1998 | Data & Knowledge Engineering1998，25，2： | 1 |
| 14 | Knowledge Engineering Principles and Methods 显示文摘 | Studer R Benjamins V R Fensel D | 1998 | Data and Knowledge Engineering1998，25，12： | 1 |
| 15 | Adsorption of natural organic matter (NOM) on iron oxide: Effects on NOM composition and formation of organo-halide compounds during chlorination显示文摘 | Korshin G V Benjamin M M Sletten R S | 1997 | Water Research1997，31，7： | 1 |
| 16 | Tuberculum sellae meningiomas:microsurgical anatomy and surgical technique显示文摘 | Benjamin V | 2002 | Neurosurgery2002，51，6： | 1 |
| 17 | Knowledge engineering: principles and metholds显示文摘 | STUDER R BENJAMINS V R FENSEL D | 1998 | Data and Knowlege Engineering1998，25，122： | 1 |
| 18 | Knowledge engineering,prin- ciples and methods显示文摘 | Studer R Benjamins V R Fensel D | 1998 | Data and Knowledge Engineering1998，25，112： | 1 |
| 19 | Knowledge Engineering:Principles and Methods显示文摘 | Studer R Benjamins V R Fenesel D | 1998 | Data and Knowledge Engineer-ing1998，25，12： | 1 |
| 20 | Knowledge Engineering,Principles and Methods显示文摘 | Studer R Benjamins V R Fensel D | 1998 | Data and Knowledge Engineering1998，25，122： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员